Anti-T-cell-antibody prophylaxis in children: success with a novel combination strategy of mycophenolate mofetil and antithymocyte serum

Transplant Proc. 1997 Dec;29(8A):16S-20S. doi: 10.1016/s0041-1345(97)00850-6.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Controlled Clinical Trial

MeSH terms

  • Adolescent
  • Antilymphocyte Serum / therapeutic use*
  • Azathioprine / therapeutic use
  • Child
  • Child, Preschool
  • Combined Modality Therapy
  • Cyclosporine / therapeutic use
  • Drug Therapy, Combination
  • Female
  • Graft Rejection / epidemiology
  • Graft Rejection / prevention & control*
  • Heart Transplantation / immunology*
  • Humans
  • Immunosuppression Therapy / methods*
  • Immunosuppressive Agents / therapeutic use*
  • Male
  • Methylprednisolone / therapeutic use
  • Mycophenolic Acid / analogs & derivatives*
  • Mycophenolic Acid / therapeutic use
  • T-Lymphocytes / immunology*
  • Time Factors

Substances

  • Antilymphocyte Serum
  • Immunosuppressive Agents
  • Cyclosporine
  • Mycophenolic Acid
  • Azathioprine
  • Methylprednisolone